Clinical trials
Phase 1/2 trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
100 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 10 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 16 |
| 2025 | 15 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 35 |
| Completed | 28 |
| Terminated | 16 |
| Active, not recruiting | 15 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arrowhead Pharmaceuticals | 11 |
| Hoffmann-La Roche | 9 |
| Merck Sharp & Dohme LLC | 7 |
| Kriya Therapeutics, Inc. | 4 |
| BeOne Medicines | 3 |
| BeiGene | 2 |
| Dynavax Technologies Corporation | 2 |
| Intellia Therapeutics | 2 |
| Sarepta Therapeutics, Inc. | 2 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Recurrence | 4 |
| alpha 1-Antitrypsin Deficiency | 4 |
| Carcinoma, Renal Cell | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Multiple Myeloma | 3 |
| Muscular Dystrophy, Facioscapulohumeral | 3 |
| Neoplasm Metastasis | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
Trials
Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.